Inactivated Vaccines Market 2027 Type, Method, Route of Administration | The Insight Partners

Inactivated Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ( Viral Vaccine, Bacterial Vaccine ); Method ( Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Others ); Route of Administration ( Oral, Subcutaneous, Intravenous, Others )

Report Code: TIPRE00010958 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

A biological preparation that enhances acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body's immune system is stimulated by the agent, which is recognized as a foreign body by this immune system. The agent is then destroyed and remembered by the immune system. The vaccine agents are inactivated or killed in different ways to reduce infectivity in order to avoid vaccine infections.

MARKET DYNAMICS

The inactivated vaccines market is driving due to the rising demand for inactivated vaccines from governments of industrialized and developing countries. However, stringent government regulations regarding efficacy and safety and lack of supply of vaccines in remote areas is likely to restraint the market growth during the forecast period. Moreover, prevalence of infectious diseases and rise in awareness among people about immunization are other factors propelling the market.

MARKET SCOPE

The "Inactivated Vaccines Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of inactivated vaccines market with detailed market segmentation by type, method and route of administration. The inactivated vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in inactivated vaccines market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The inactivated vaccines market is segmented on the basis of type, method and route of administration. Based on type, the market is segmented as viral vaccine and bacterial vaccine. On the basis of method, the market is categorized as solvent detergent method, radiation method, pH concentration, heat inactivation and others. On the basis of route of administration, the market is categorized as oral, subcutaneous, intravenous and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the inactivated vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The inactivated vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting inactivated vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the inactivated vaccines market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the inactivated vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from inactivated vaccines market are anticipated to have lucrative growth opportunities in the future with the rising demand for inactivated vaccines in the global market. Below mentioned is the list of few companies engaged in the inactivated vaccines market.

The report also includes the profiles of key players in inactivated vaccines market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


    - Bharat Biotech
    - CSL Ltd.
    - Emergent BioSolutions
    - GlaxoSmithKline plc
    - Merck & Co., Inc.
    - Novartis AG
    - Pfizer Inc.
    - Sanofi
    - Seqirus
    - Valneva SE


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inactivated Vaccines Market - By Type
1.3.2 Inactivated Vaccines Market - By Method
1.3.3 Inactivated Vaccines Market - By Route of Administration
1.3.4 Inactivated Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INACTIVATED VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INACTIVATED VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INACTIVATED VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. INACTIVATED VACCINES - GLOBAL MARKET OVERVIEW
6.2. INACTIVATED VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. VIRAL VACCINE
7.3.1. Overview
7.3.2. Viral Vaccine Market Forecast and Analysis
7.4. BACTERIAL VACCINE
7.4.1. Overview
7.4.2. Bacterial Vaccine Market Forecast and Analysis
8. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - METHOD
8.1. OVERVIEW
8.2. METHOD MARKET FORECASTS AND ANALYSIS
8.3. SOLVENT DETERGENT METHOD
8.3.1. Overview
8.3.2. Solvent Detergent Method Market Forecast and Analysis
8.4. RADIATION METHOD
8.4.1. Overview
8.4.2. Radiation Method Market Forecast and Analysis
8.5. PH CONCENTRATION
8.5.1. Overview
8.5.2. pH Concentration Market Forecast and Analysis
8.6. HEAT INACTIVATION
8.6.1. Overview
8.6.2. Heat Inactivation Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. INACTIVATED VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. SUBCUTANEOUS
9.4.1. Overview
9.4.2. Subcutaneous Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. INACTIVATED VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Inactivated Vaccines Market Overview
10.1.2 North America Inactivated Vaccines Market Forecasts and Analysis
10.1.3 North America Inactivated Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Inactivated Vaccines Market Forecasts and Analysis - By Method
10.1.5 North America Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.1.6 North America Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Inactivated Vaccines Market
10.1.6.1.1 United States Inactivated Vaccines Market by Type
10.1.6.1.2 United States Inactivated Vaccines Market by Method
10.1.6.1.3 United States Inactivated Vaccines Market by Route of Administration
10.1.6.2 Canada Inactivated Vaccines Market
10.1.6.2.1 Canada Inactivated Vaccines Market by Type
10.1.6.2.2 Canada Inactivated Vaccines Market by Method
10.1.6.2.3 Canada Inactivated Vaccines Market by Route of Administration
10.1.6.3 Mexico Inactivated Vaccines Market
10.1.6.3.1 Mexico Inactivated Vaccines Market by Type
10.1.6.3.2 Mexico Inactivated Vaccines Market by Method
10.1.6.3.3 Mexico Inactivated Vaccines Market by Route of Administration
10.2. EUROPE
10.2.1 Europe Inactivated Vaccines Market Overview
10.2.2 Europe Inactivated Vaccines Market Forecasts and Analysis
10.2.3 Europe Inactivated Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Inactivated Vaccines Market Forecasts and Analysis - By Method
10.2.5 Europe Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.2.6 Europe Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Inactivated Vaccines Market
10.2.6.1.1 Germany Inactivated Vaccines Market by Type
10.2.6.1.2 Germany Inactivated Vaccines Market by Method
10.2.6.1.3 Germany Inactivated Vaccines Market by Route of Administration
10.2.6.2 France Inactivated Vaccines Market
10.2.6.2.1 France Inactivated Vaccines Market by Type
10.2.6.2.2 France Inactivated Vaccines Market by Method
10.2.6.2.3 France Inactivated Vaccines Market by Route of Administration
10.2.6.3 Italy Inactivated Vaccines Market
10.2.6.3.1 Italy Inactivated Vaccines Market by Type
10.2.6.3.2 Italy Inactivated Vaccines Market by Method
10.2.6.3.3 Italy Inactivated Vaccines Market by Route of Administration
10.2.6.4 Spain Inactivated Vaccines Market
10.2.6.4.1 Spain Inactivated Vaccines Market by Type
10.2.6.4.2 Spain Inactivated Vaccines Market by Method
10.2.6.4.3 Spain Inactivated Vaccines Market by Route of Administration
10.2.6.5 United Kingdom Inactivated Vaccines Market
10.2.6.5.1 United Kingdom Inactivated Vaccines Market by Type
10.2.6.5.2 United Kingdom Inactivated Vaccines Market by Method
10.2.6.5.3 United Kingdom Inactivated Vaccines Market by Route of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Inactivated Vaccines Market Overview
10.3.2 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Method
10.3.5 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.3.6 Asia-Pacific Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Inactivated Vaccines Market
10.3.6.1.1 Australia Inactivated Vaccines Market by Type
10.3.6.1.2 Australia Inactivated Vaccines Market by Method
10.3.6.1.3 Australia Inactivated Vaccines Market by Route of Administration
10.3.6.2 China Inactivated Vaccines Market
10.3.6.2.1 China Inactivated Vaccines Market by Type
10.3.6.2.2 China Inactivated Vaccines Market by Method
10.3.6.2.3 China Inactivated Vaccines Market by Route of Administration
10.3.6.3 India Inactivated Vaccines Market
10.3.6.3.1 India Inactivated Vaccines Market by Type
10.3.6.3.2 India Inactivated Vaccines Market by Method
10.3.6.3.3 India Inactivated Vaccines Market by Route of Administration
10.3.6.4 Japan Inactivated Vaccines Market
10.3.6.4.1 Japan Inactivated Vaccines Market by Type
10.3.6.4.2 Japan Inactivated Vaccines Market by Method
10.3.6.4.3 Japan Inactivated Vaccines Market by Route of Administration
10.3.6.5 South Korea Inactivated Vaccines Market
10.3.6.5.1 South Korea Inactivated Vaccines Market by Type
10.3.6.5.2 South Korea Inactivated Vaccines Market by Method
10.3.6.5.3 South Korea Inactivated Vaccines Market by Route of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Inactivated Vaccines Market Overview
10.4.2 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Method
10.4.5 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.4.6 Middle East and Africa Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Inactivated Vaccines Market
10.4.6.1.1 South Africa Inactivated Vaccines Market by Type
10.4.6.1.2 South Africa Inactivated Vaccines Market by Method
10.4.6.1.3 South Africa Inactivated Vaccines Market by Route of Administration
10.4.6.2 Saudi Arabia Inactivated Vaccines Market
10.4.6.2.1 Saudi Arabia Inactivated Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Inactivated Vaccines Market by Method
10.4.6.2.3 Saudi Arabia Inactivated Vaccines Market by Route of Administration
10.4.6.3 U.A.E Inactivated Vaccines Market
10.4.6.3.1 U.A.E Inactivated Vaccines Market by Type
10.4.6.3.2 U.A.E Inactivated Vaccines Market by Method
10.4.6.3.3 U.A.E Inactivated Vaccines Market by Route of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Inactivated Vaccines Market Overview
10.5.2 South and Central America Inactivated Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Method
10.5.5 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Route of Administration
10.5.6 South and Central America Inactivated Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Inactivated Vaccines Market
10.5.6.1.1 Brazil Inactivated Vaccines Market by Type
10.5.6.1.2 Brazil Inactivated Vaccines Market by Method
10.5.6.1.3 Brazil Inactivated Vaccines Market by Route of Administration
10.5.6.2 Argentina Inactivated Vaccines Market
10.5.6.2.1 Argentina Inactivated Vaccines Market by Type
10.5.6.2.2 Argentina Inactivated Vaccines Market by Method
10.5.6.2.3 Argentina Inactivated Vaccines Market by Route of Administration
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INACTIVATED VACCINES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INACTIVATED VACCINES MARKET, KEY COMPANY PROFILES
13.1. BHARAT BIOTECH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CSL LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. EMERGENT BIOSOLUTIONS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERCK AND CO., INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PFIZER INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SANOFI
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SEQIRUS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VALNEVA SE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bharat Biotech
2. CSL Ltd.
3. Emergent BioSolutions
4. GlaxoSmithKline plc
5. Merck & Co., Inc.
6. Novartis AG
7. Pfizer Inc.
8. Sanofi
9. Seqirus
10. Valneva SE
TIPRE00010958
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking